Helicobacter pylon serology in patients with chronic gastritis

American Journal of Gastroenterology

Volumn 91, Issue 5, 1996, Pages 954-958

  Plebani, Mario ^a,b   Basso, Daniela ^a   Cassaro, Mauro ^a   Brigato, Luca ^a   Scrigner, Marina ^a   Toma, Andrea ^a   Di Mario, Francesco ^a   Rugge, Massimo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY SPECIFICITY; ARTICLE; CHRONIC GASTRITIS; DIAGNOSTIC ACCURACY; DYSPEPSIA; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEROLOGY; STOMACH EPITHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; FEMALE; GASTRINS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PEPSINOGENS; SEROLOGIC TESTS;

EID: 0029884002     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273 (letter).
2. Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-5 (letter).
3. Rauws EAJ, Langenberg W, Houthoff HJ, et al. Campylobacter pyloridis-associated chronic antral gastritis. Gastroenterology 1988;94:33-40.
4. Blaser MJ. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 1990;161:626-33.
5. Biasco G, Paganelli GM, Santucci R, et al. The relationship between type A and B gastritis and Helicobacter pylori. Eur J Gastroenterol Hepatol 1993;5(suppl 2):S67-9.
6. Peterson WL. Helicobacter pylori and peptic ulcer disease. N Engl J Med 1991;324:1043-8.
7. Megraud F, Lamouliatte H. Helicobacter pylori and duodenal ulcer. Evidence suggesting causation. Dig Dis Sci 1992;37:769-72.
8. Saita H, Murakami M, Yoo JK, et al. Link between Helicobacter pylori-associated gastritis and duodenal ulcer. Dig Dis Sci 1993;38: 117-22.
9. Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994;35:19-22.
10. Hansson LE, Engstrand L, Nyren O, et al. Helicobacter pylori: Independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993;105:1098-103.
11. Fiocca R, Luinetti O, Villani L, et al. High incidence of Helicobacter pylori colonization in early gastric cancer and the possible relationship to carcinogenesis. Eur J Gastroenterol Hepatol 1993;5(suppl 2):S2-8.
12. Moss SF, Legon S, Bishop AE, et al. Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992;340: 930-2.
13. Graham DY, Lew G, Lechago J. Antral G-cells and D-cells numbers in Helicobacter pylori infection. Effect of H. pylori eradication. Gastroenterology 1993;104:1655-60.
14. Graham DY, Opekun A, Lew GM, et al. Helicobacter pylori-associated exaggerated gastrin release in duodenal ulcer patients. The effect of bombesin infusion and urea ingestion. Gastroenterology 1991;100: 1571-5.
15. Newell DG, Rathbone BJ. The serodiagnosis of Campylobacter pylori infection. Serodiag Immunother Infect Dis 1989;3:1-7.
16. Kosunen TU, Seppala K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
17. Louw JA, Falck V van Rensburg C, et al. Distribution of Helicobacter pylori colonisation and associated gastric inflammatory changes: Differences between patients with duodenal and gastric ulcers. J Clin Pathol 1993;46:754-6.
18. Crabtree JE, Farmery SM, Lindley IJD, et al. CagA/cytotoxis strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994;47:945-50.
19. Plebani M. Pepsinogens in health and disease. Clin Lab Sci 1993;30: 273-328.
20. Plebani M, Di Mario F, Stanghellini V, et al. Serological tests to monitor treatment of Helicobacter pylori. Lancet 1992;340:51-2 (letter).
21. Hunter FM, Correa P, Fontham E, et al. Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis. Dig Dis Sci 1993;38:2081-6.
22. Wagner S, Haruma K, Gladziwa U, et al. Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: Significance of inflammation and effect of bacterial eradication. Am J Gastroenterol 1994;89:1211-8.
23. Di Mario F, Plebani M, Gottardello L, et al. Role of serum fasting gastrin in screening for hypergastrinemic syndromes in duodenal disease. Clin Biochem 1992;25:121-4.
24. Plebani M, Di Mario F, Vianello F, et al. Pepsinogen group I radioimmunoassay and total serum pepsinogen colorimetric determination: A comparative study in normal subjects and in peptic ulcer patients. Clin Biochem 1983;16:20-2.
25. Plebani M, Masiero M, Di Mario F, et al. Radioimmunoassay for pepsinogen C. Clin Biochem 1990;36:1690.
26. Plebani M, Basso D, Venturini R, et al. Usefulness of two different assays for serodiagnosis of Helicobacter pylori infection. Eur J Lab Med 1993;1:9-12.
27. Corinaldesi R, Tucci A, Poli L, et al. Treatment of Helicobacter pylori-positive functional dyspepsia. Eur J Gastroenterol Hepatol 1993;5(suppl 2):S79-81.
28. Yoshida N, Granger DN, Evans DJ, et al. Mechanisms involved in Helicobacter pylori-induced inflammation. Gastroenterology 1993; 105:1431-40.
29. Catrenich CE, Makin KM. Characterization of the morphologic conversion of Helicobacter pylori from bacillary to coccoid forms. Scand J Gastroenterol 1991;26(suppl 181):58-64.